Cargando…

Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis

BACKGROUND AND OBJECTIVES: Anti-NMDA receptor (NMDAR) encephalitis is defined by the presence of antibodies (Abs) targeting the NMDAR in the CSF. This study aimed to determine the prognostic value of persistent CSF NMDAR-Abs during follow-up. METHODS: This retrospective observational study included...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciano-Petersen, Nicolás Lundahl, Robert, Mélisse, Muñiz-Castrillo, Sergio, Wucher, Valentin, Klich, Amna, Vogrig, Alberto, Villagrán García, Macarena, Farina, Antonio, Goncalves, David, Picard, Geraldine, Rogemond, Veronique, Joubert, Bastien, Oliver-Martos, Begoña, Serrano-Castro, Pedro J., Maucort-Boulch, Delphine, Honnorat, Jerome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162705/ https://www.ncbi.nlm.nih.gov/pubmed/37147137 http://dx.doi.org/10.1212/NXI.0000000000200108

Ejemplares similares

Cytokine dynamics and targeted immunotherapies in autoimmune encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2022)

Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
por: Farina, Antonio, et al.
Publicado: (2022)

Revisiting anti-Hu paraneoplastic autoimmunity: phenotypic characterization and cancer diagnosis
por: Villagrán-García, Macarena, et al.
Publicado: (2023)

Neurological outcomes in immune checkpoint inhibitor-related neurotoxicity
por: Farina, Antonio, et al.
Publicado: (2023)

CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitis
por: Desestret, Virginie, et al.
Publicado: (2015)

Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes
por: Déchelotte, Benoît, et al.
Publicado: (2020)

Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis
por: Benoit, Jeanne, et al.
Publicado: (2022)

Pathophysiology of paraneoplastic and autoimmune encephalitis: genes, infections, and checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2020)

Current Status of Biomarkers in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2021)

Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies
por: Simard, Claire, et al.
Publicado: (2020)

Epidemiology of paraneoplastic neurologic syndromes and autoimmune encephalitides in France
por: Hébert, Julien, et al.
Publicado: (2020)

Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review
por: Alentorn, Agustí, et al.
Publicado: (2023)

Associations between HLA and autoimmune neurological diseases with autoantibodies
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2020)

Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic Features
por: Peter, Elise, et al.
Publicado: (2022)

Neuroleptic intolerance in patients with anti-NMDAR encephalitis
por: Lejuste, Florian, et al.
Publicado: (2016)

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
por: Vogrig, Alberto, et al.
Publicado: (2019)

Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
por: Muñiz-Castrillo, Sergio, et al.
Publicado: (2021)

Editorial: Neuroglial antibodies: From clinical associations to pathophysiological investigations
por: Vogrig, Alberto, et al.
Publicado: (2023)

Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)
por: Manto, Mario, et al.
Publicado: (2023)

Argonaute Autoantibodies as Biomarkers in Autoimmune Neurologic Diseases
por: Do, Le-Duy, et al.
Publicado: (2021)

Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo–Associated Paraneoplastic Cerebellar Degeneration
por: Peter, Elise, et al.
Publicado: (2022)

Multiplex family with GAD65-Abs neurologic syndromes
por: Belbezier, Aude, et al.
Publicado: (2017)

Anti-LGI1 Encephalitis With Co-occurring IgLON5 Antibodies: Clinical Features and Human Leukocyte Antigen Haplotypes
por: Schiff, Pierre, et al.
Publicado: (2023)

Immunopathogenesis and proposed clinical score for identifying Kelch-like protein-11 encephalitis
por: Vogrig, Alberto, et al.
Publicado: (2021)

Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis
por: Joubert, Bastien, et al.
Publicado: (2017)

CSF Findings in Acute NMDAR and LGI1 Antibody–Associated Autoimmune Encephalitis
por: Dürr, Marc, et al.
Publicado: (2021)

Elevation of YKL-40 in the CSF of Anti-NMDAR Encephalitis Patients Is Associated With Poor Prognosis
por: Chen, Jinyu, et al.
Publicado: (2018)

Placental transfer of NMDAR antibodies causes reversible alterations in mice
por: García-Serra, Anna, et al.
Publicado: (2020)

Variance component analysis to assess protein quantification in biomarker validation: application to selected reaction monitoring-mass spectrometry
por: Klich, Amna, et al.
Publicado: (2018)

Cell-Free Mitochondrial DNA in the CSF: A Potential Prognostic Biomarker of Anti-NMDAR Encephalitis
por: Peng, Yu, et al.
Publicado: (2019)

Methionine tumor starvation by erythrocyte‐encapsulated methionine gamma‐lyase activity controlled with per os vitamin B6
por: Gay, Fabien, et al.
Publicado: (2017)

Comparative optimism in models involving both classical clinical and gene expression information
por: Truntzer, Caroline, et al.
Publicado: (2008)

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021)

CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
por: Nissen, Mette Scheller, et al.
Publicado: (2021)

Cytokine/chemokine levels in the CSF and serum of anti-NMDAR encephalitis: A systematic review and meta-analysis
por: Ma, Yushan, et al.
Publicado: (2023)

Conformation-stabilizing ELISA and cell-based assays reveal patient subgroups targeting three different epitopes of AGO1 antibodies
por: Moritz, Christian P., et al.
Publicado: (2022)

Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis
por: Kothur, Kavitha, et al.
Publicado: (2016)

Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
por: Tominaga, Naomi, et al.
Publicado: (2018)

Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia
por: Manto, Mario U, et al.
Publicado: (2011)

Intrathecal Rituximab as a Rescue Therapy in Refractory Pure CSF Positive, Non-Teratomatous Type Anti-NMDAR Encephalitis
por: Krishnan, Parameswaran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g3sul8qgn4cvlgehrkmdoutqrc